Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.370
-0.090 (-6.16%)
At close: Apr 1, 2025, 4:00 PM
1.420
+0.050 (3.65%)
After-hours: Apr 1, 2025, 7:59 PM EDT

Allogene Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
2984475409072,1263,541
Upgrade
Market Cap Growth
-17.32%-17.32%-40.45%-57.34%-39.95%11.80%
Upgrade
Enterprise Value
962481714571,6972,753
Upgrade
Last Close Price
1.372.133.216.2914.9225.24
Upgrade
PS Ratio
13529.6720300.075685.985814.6318.64-
Upgrade
PB Ratio
0.691.061.061.362.323.28
Upgrade
P/TBV Ratio
1.061.061.061.362.323.28
Upgrade
EV/Sales Ratio
4360.5811252.801803.612931.9914.87-
Upgrade
Debt / Equity Ratio
0.220.220.190.150.080.05
Upgrade
Asset Turnover
00000.10-
Upgrade
Quick Ratio
8.298.2912.159.699.628.85
Upgrade
Current Ratio
8.548.5412.389.849.788.96
Upgrade
Return on Equity (ROE)
-55.13%-55.13%-55.51%-43.00%-18.24%-37.03%
Upgrade
Return on Assets (ROA)
-27.01%-27.01%-26.84%-22.55%-9.94%-16.59%
Upgrade
Return on Capital (ROIC)
-28.73%-28.73%-28.58%-23.86%-10.61%-17.78%
Upgrade
Earnings Yield
-86.54%-57.68%-60.59%-37.53%-8.56%-8.94%
Upgrade
FCF Yield
-67.53%-45.01%-44.29%-24.88%-9.70%-5.11%
Upgrade
Buyback Yield / Dilution
-24.14%-24.14%-9.63%-5.39%-12.84%-19.11%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q